TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study
Aimin Jiang(Second Military Medical University), Linhui Wang(Second Military Medical University), Peng Luo(Zhujiang Hospital), Yu Fang(Second Military Medical University), Qiwei Yang(Second Affiliated Hospital of Jilin University), Le Qu(Nanjing General Hospital of Nanjing Military Command), Huamao Ye(Second Military Medical University), Bicheng Ye(Zhongda Hospital Southeast University), Wenqiang Liu(Jinzhou Medical University), Wenhao Xu(Shanghai Jiao Tong University), Ziwei He(Second Military Medical University), Baohua Zhu(Second Military Medical University), Shunxiang Gao(Shanghai Jiao Tong University), Xiaofeng Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying Liu(Second Military Medical University)
Cited by 9
Related Papers
Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA
|Cancer Cell|2016|1.2k
Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling
|Molecular Cancer|2017|257
Clinical and molecular effects on mature burn scars after treatment with a fractional CO<sub>2</sub> laser
|Lasers in Surgery and Medicine|2012|153
Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma
|European Urology|2018|152